Home | Contact Us | FAQ | Search & Site Map | Link to Us
Sign In | Join | Other 45 Sites in Network
Home
Discussion Groups
General
GeneralCardiologyVisionDentistryPharmacyLaboratoryNutritionAlternative
Diseases and Disorders
AIDSAlzheimer'sArthritisAsthmaCancerBreast CancerDiabetesEpilepsyGlaucomaHepatitisHerpesLupusProstate BPHProstate CancerProstatitisSinusitisTinnitus

Medical Forum / Diseases and Disorders / Prostate Cancer / November 2007

Tip: Looking for answers? Try searching our database.

PSA Velocity in Men With Total PSA Less Than 4 ng/ml

Thread view: 
Enable EMail Alerts  Start New Thread
Thread rating: 
ron - 09 Nov 2007 15:50 GMT
Article by Dr. Catalona suggesting a different PSA velocity cutpoint
for untreated men with a PSA in the 4-10 range vs. men with a PSA less
than 4 ng/ml...ron
--------------------------------------------------------------------------------------------------------------------------------------

J Urol. 2007 Oct 12; Vol. 178, Issue 6, pp 2348-53

Prostate Specific Antigen Velocity in Men With Total Prostate Specific
Antigen Less Than 4 ng/ml.

Loeb S, Roehl KA, Nadler RB, Yu X, Catalona WJ.

Department of Urology, the James Buchanan Brady Urological Institute,
the Johns Hopkins Medical Institutions, Baltimore, Maryland (SL).

PURPOSE: A prostate specific antigen velocity threshold of 0.75 ng/ml
per year has commonly been used to distinguish men with prostate
cancer from those with benign prostate conditions. In addition, a
prostate specific antigen velocity greater than 2 ng/ml per year has
been linked to an increased prostate cancer specific mortality rate
after radical prostatectomy and after radiation therapy. However, both
of these frequently cited thresholds were determined largely in groups
of men with a prostate specific antigen greater than 4 ng/ml.
MATERIALS AND METHODS: Of approximately 26,000 men who participated in
a prostate cancer screening study 22,019 had a prostate specific
antigen of 4 ng/ml or less. Of these men 501 were diagnosed with
prostate cancer and had sufficient data for a prostate specific
antigen velocity calculation. We performed univariate and multivariate
analyses to compare cancer detection rates and performance
characteristics using various prostate specific antigen velocity
thresholds in these men.
RESULTS: In men with a prostate specific antigen less than 4 ng/ml, a
prostate specific antigen velocity threshold of 0.4 ng/ml per year was
most useful for recommending prostate biopsy. Overall prostate cancer
was diagnosed in 223 (2%) men with a prostate specific antigen
velocity less than 0.4 ng/ml per year compared to 278 (13%) men with a
prostate specific antigen velocity greater than 0.4 ng/ml per year (p
<0.0001). On multivariate analysis a prostate specific antigen
velocity greater than 0.4 ng/ml per year was a stronger independent
predictor of prostate cancer diagnosis than age, race or a family
history of prostate cancer.
CONCLUSIONS: The traditional prostate specific antigen threshold of
0.75 ng/ml per year was determined largely in men with a total
prostate specific antigen of 4 to 10 ng/ml. Prostate specific antigen
velocity thresholds in the range of 0.4 ng/ml per year should be used
to help guide the need for biopsy in men with a total prostate
specific antigen less than 4 ng/ml.

PMID: 17936844
Leonard Evens - 09 Nov 2007 17:13 GMT
> Article by Dr. Catalona suggesting a different PSA velocity cutpoint
> for untreated men with a PSA in the 4-10 range vs. men with a PSA less
[quoted text clipped - 45 lines]
>
> PMID: 17936844

That is very interesting.  Had we used this criterion, I probably would
have been diagnosed a year earlier.   My Gleason score might have been
6=3+3 instead of 7=3+4.   As it turned out my post surgical pathology
looked very good, and my chances of recurrence are quite low.  So
perhaps it didn't really matter in the end.
gvk2six@yahoo.com - 10 Nov 2007 07:29 GMT
> Article by Dr. Catalona suggesting a different PSA velocity cutpoint

> Overall prostate cancer
> was diagnosed in 223 (2%) men with a prostate specific antigen
> velocity less than 0.4 ng/ml per year compared to 278 (13%) men with a
> prostate specific antigen velocity greater than 0.4 ng/ml per year (p
> <0.0001).

> CONCLUSIONS: Prostate specific antigen
> velocity thresholds in the range of 0.4 ng/ml per year should be used
> to help guide the need for biopsy in men with a total prostate
> specific antigen less than 4 ng/ml.

Tried ot look at the full text, but you need to pay.
I'd certainly want to look at the data before I accepted his new .4
cutoff.
Under .4  was 2% while .4 and over was 13%
2% to 13%.....thats a huge difference.  I'd like to see the gradation
between 2 and 13 percent and whats included in the over .4 group.
What are the .5, .6, and .75 percentages that weight the .4 cutoff?
This is a continuum.  Whats the difference between the group from .35
to .40 and the group from .40 to .45.
Or is it just too late and I'm not thinking straight?
BTW, am I the only one thinking 13% is not all that high?

Using Dr. Catalona's two criteria,  .4 acceleration along with his 2.5
psa threshold,  it looks like we'll be tripling the number of biopsies
and probably doubling the numbers of prostate cancers found.
If, as many suggest,  we are over treating now,  then what will be
happening with the new standards set at .4 and 2.5 ?

Perhaps someone will post the data I am asking about.
rosbif - 10 Nov 2007 09:24 GMT
>> Article by Dr. Catalona suggesting a different PSA velocity cutpoint
>
[quoted text clipped - 28 lines]
>
>Perhaps someone will post the data I am asking about.

I don't have the data but it must be, as you say above, a continuum.
We're constantly being shoved into 2 or perhaps 3 categories, mild
medium and/or strong and it becomes impossible to make any sense of
the results for those who sit on the breakpoints; it's quite
improbable that the prospects for a particular 0.39/yr are going to be
markedly different from those of a 0.41.

I note 0.4 in 4, (10%) would equate to an approx 7 year doubling time
assuming a geometric rise.  7 years or above still looks like a
comfort zone to me.  And yes, I think you're right, 13% is not all
that high.

As things stand, if I were not too young, PSA</=4 with an estimated
doubling >/=7 years, I would probably sit tight and forego the biopsy
for a couple of years to get a little more precision on the velocity
curve.  I don't advocate it, but I think it's what I would do.
KeithLundy - 14 Nov 2007 02:40 GMT
hello ron....it is great to know that you continue to contribute, to the
group, great information.....i had proton (only) at loma linda and
continue to do well since my treatment ended in may 03.....if there are
any positive or negative issues after my 5yr anniversary, i will certainly
share it with the group......
ron - 14 Nov 2007 14:24 GMT
> hello ron....it is great to know that you continue to contribute, to the
> group, great information.....i had proton (only) at loma linda and
> continue to do well since my treatment ended in may 03.....if there are
> any positive or negative issues after my 5yr anniversary, i will certainly
> share it with the group......

Hi Keith...Glad to hear that things are going so well.  Five years is
a milestone, good luck on the check up!..Best wishes and good health,
ron
WhiteSoxFan - 14 Nov 2007 16:48 GMT
> Article by Dr. Catalona suggesting a different PSA velocity cutpoint
> for untreated men with a PSA in the 4-10 range vs. men with a PSA less
> than 4 ng/ml...ron

If my primary doc had known this advice back when my psa was 3.26 and
sounded the alarm, I may have found out then that my maternal
grandfather had pCa. I would have then closely monitored my velocity
or had a biopsy then instead of going to a different primary doctor
for insurance reasons, that diddn't even proscribe a psa test for me
when I was 49. I partly take the blame for that oversight by not
coordinating my prior records to the new primary doc. It wasn't until
the next primary doctor red flagged the 4.2 psa I showed when I was 52
had a positive biopsy and I found out then that my maternal
grandfather had pCA and ...well the rest is historic enough for me to
be here posting. On a separate note, I always am conflicted to
announce the good news that I passed another post op 3 month psa test
resulting in another <0.1 knowing there are many here that do not get
this good news. I've now thrown 7 aces in a row. But I feel it helps
many in similar circumstances to maintain a positive attitude. I've
been off of 9 months of HT (hormone therapy) for 10 months now, can
say I feel as good as I did post HT, the body hair has returned, am no
longer a second slow with awareness on the B'ball court, T has
returned to normal levels. I will also add that I convinced my onc to
have me take the tests to baseline the assays for the other biomarkers
other than psa because of my Gleason 8. Thanks to Steve Jordan or was
it Steve Kramer, for that bit of knowledge. Regardless of the Steve,
you've both been a wonderful source of information and support.

Thanks,

WhiteSoxFan
Steve Kramer - 15 Nov 2007 00:02 GMT
> On a separate note, I always am conflicted to
> announce the good news that I passed another post op 3 month psa test
> resulting in another <0.1 knowing there are many here that do not get
> this good news. I've now thrown 7 aces in a row. But I feel it helps
> many in similar circumstances to maintain a positive attitude.

No need to be conflicted.  I don't think there is a man (or SO) here that
does not like to see when one of us has good news.  It's a support group,
not a contest.  We share in all the cicumstances; agony and ecxtacy.

> I will also add that I convinced my onc to
> have me take the tests to baseline the assays for the other biomarkers
> other than psa because of my Gleason 8. Thanks to Steve Jordan or was
> it Steve Kramer, for that bit of knowledge.

That would be Jordan.  I wonderful asset to this forum.
 
Sign In
Join
My Latest Posts
My Monitored Threads
My Blog
My Photo Gallery
My Profile
My Homepage

Start New Thread
Enable EMail Alerts
Rate this Thread



©2008 Advenet LLC   Privacy Policy - Terms of Use
This website includes both content owned or controlled by Advenet as well as content owned or controlled by third parties.